Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-12-15

FDA Approved: HYDROMET — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for HYDROMET (hydrocodone bitartrate and homatropine methylbromide) from Actavis Pharma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROMET (HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE)

Snippet

SUPPL AP for HYDROMET (HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE)